LTX-109

Search structure
Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: HO813QDF65

Structure
InChI Key ZVOYWSKEBVVLGW-ZDCRTTOTSA-N
Smile CC(C)(C)c1cc(C(C)(C)C)c2[nH]c(C(C)(C)C)c(C[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCc3ccccc3)c2c1
InChI
InChI=1S/C43H69N11O3/c1-41(2,3)27-23-28-29(35(43(7,8)9)54-34(28)30(24-27)42(4,5)6)25-33(53-36(55)31(44)17-13-20-50-39(45)46)38(57)52-32(18-14-21-51-40(47)48)37(56)49-22-19-26-15-11-10-12-16-26/h10-12,15-16,23-24,31-33,54H,13-14,17-22,25,44H2,1-9H3,(H,49,56)(H,52,57)(H,53,55)(H4,45,46,50)(H4,47,48,51)/t31-,32-,33-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C43H69N11O3
Molecular Weight 788.1
AlogP 3.79
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 11.0
Number of Rotational Bond 18.0
Polar Surface Area 252.91
Molecular species BASE
Aromatic Rings 3.0
Heavy Atoms 57.0

Pharmacology

Action Mechanism of Action Reference
DISRUPTING AGENT Cell membrane disrupting agent PubMed PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Impetigo 2 D007169 ClinicalTrials
Severe Acute Respiratory Syndrome 2 D045169 ClinicalTrials
Staphylococcal Infections 1 D013203 ClinicalTrials
Hidradenitis Suppurativa 1 D017497 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1166254-80-3
ChEBI 77752
ChEMBL CHEMBL1817968
DrugBank DB12711
EPA CompTox DTXSID20151467
FDA SRS HO813QDF65
PubChem 25242323
SureChEMBL SCHEMBL19712240
CONTENTS